Treffer: Evaluation of enzyme activity predictions for variants of unknown significance in Arylsulfatase A.
Original Publication: Berlin, New York, Springer-Verlag.
FEBS Lett. 2016 Aug;590(15):2327-41. (PMID: 27423136)
Orphanet J Rare Dis. 2022 Jun 18;17(1):233. (PMID: 35717227)
Orphanet J Rare Dis. 2020 Nov 18;15(1):324. (PMID: 33208168)
Proteins. 2021 Dec;89(12):1607-1617. (PMID: 34533838)
Hum Mutat. 2011 Aug;32(8):894-9. (PMID: 21520341)
Genome Biol. 2024 Feb 22;25(1):53. (PMID: 38389099)
Genome Med. 2023 Nov 30;15(1):103. (PMID: 38037155)
Nat Rev Genet. 2023 Nov;24(11):755-766. (PMID: 37386126)
Genet Med. 2015 May;17(5):405-24. (PMID: 25741868)
Nat Methods. 2010 Apr;7(4):248-9. (PMID: 20354512)
Cytotherapy. 2024 Jul;26(7):739-748. (PMID: 38613540)
Bioinformatics. 2022 Nov 30;38(23):5168-5174. (PMID: 36227117)
Nat Commun. 2021 Apr 13;12(1):2224. (PMID: 33850126)
Nucleic Acids Res. 2018 Jan 4;46(D1):D1062-D1067. (PMID: 29165669)
Cell. 2019 Mar 21;177(1):45-57. (PMID: 30901547)
Genome Biol. 2023 Jul 21;24(1):172. (PMID: 37480112)
Genet Med. 2021 Mar;23(3):555-561. (PMID: 33214709)
Biol Blood Marrow Transplant. 2013 Apr;19(4):616-24. (PMID: 23348427)
Dement Geriatr Cogn Disord. 2001 Mar-Apr;12(2):85-8. (PMID: 11173879)
Nature. 2021 Nov;599(7883):91-95. (PMID: 34707284)
Hum Genet. 2025 Mar;144(2-3):209-225. (PMID: 39117802)
Genome Res. 2005 Aug;15(8):1034-50. (PMID: 16024819)
Nature. 2020 May;581(7809):434-443. (PMID: 32461654)
Nat Commun. 2020 Nov 20;11(1):5918. (PMID: 33219223)
Hum Mutat. 2019 Sep;40(9):1519-1529. (PMID: 31342580)
PLoS One. 2018 Jul 6;13(7):e0200008. (PMID: 29979746)
Nat Commun. 2023 Dec 14;14(1):8318. (PMID: 38097619)
Hum Genet. 2025 Mar;144(2-3):191-208. (PMID: 39048855)
Science. 2023 Sep 22;381(6664):eadg7492. (PMID: 37733863)
JAMA Netw Open. 2023 Oct 2;6(10):e2339571. (PMID: 37878314)
J Alzheimers Dis. 2016;51(3):683-7. (PMID: 26890752)
Genome Res. 2014 Dec;24(12):2050-8. (PMID: 25217195)
Hum Mutat. 2017 Sep;38(9):1092-1108. (PMID: 28508593)
Best Pract Res Clin Endocrinol Metab. 2015 Mar;29(2):261-73. (PMID: 25987178)
Radiology. 1982 Apr;143(1):29-36. (PMID: 7063747)
Science. 1974 Sep 6;185(4154):862-4. (PMID: 4843792)
Am J Hum Genet. 2016 Oct 6;99(4):877-885. (PMID: 27666373)
Biopolymers. 1983 Dec;22(12):2577-637. (PMID: 6667333)
Hum Genet. 1991 Mar;86(5):463-70. (PMID: 1673113)
Sci Rep. 2018 Mar 14;8(1):4480. (PMID: 29540703)
Weitere Informationen
Continued advances in variant effect prediction are necessary to demonstrate the ability of machine learning methods to accurately determine the clinical impact of variants of unknown significance (VUS). Towards this goal, the ARSA Critical Assessment of Genome Interpretation (CAGI) challenge was designed to characterize progress by utilizing 219 experimentally assayed missense VUS in the Arylsulfatase A (ARSA) gene to assess the performance of community-submitted predictions of variant functional effects. The challenge involved 15 teams, and evaluated additional predictions from established and recently released models. Notably, a model developed by participants of a genetics and coding bootcamp, trained with standard machine-learning tools in Python, demonstrated superior performance among submissions. Furthermore, the study observed that state-of-the-art deep learning methods provided small but statistically significant improvement in predictive performance compared to less elaborate techniques. These findings underscore the utility of variant effect prediction, and the potential for models trained with modest resources to accurately classify VUS in genetic and clinical research.
(© 2025. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)
Declarations. Conflict of interest: Wyatt T. Clark, Marena Trinidad, Courtney Astore, Teague Sterling, and Sufyan Kazi are former employees and potential shareholders of BioMarin Pharmaceutical. Rocio Acuna-Hidalgo is a current employee and shareholder of Nostos Genomics GmbH. Andrea Grafmüller and Laura T. Jiménez Barrón are former employees of Nostos Genomics GmbH. Ethics approval: Not relevant. Consent to participate: Not relevant. Consent for publication: All authors have consented to publication of this manuscript.